Xenon Pharmaceuticals Inc. - Common Stock (XENE)

234 filings reported holding XENE - Xenon Pharmaceuticals Inc. - Common Stock as of Q3 2024.
Xenon Pharmaceuticals Inc. - Common Stock (XENE) has 203 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 74.9M shares of 77.3M outstanding shares and own 96.82% of the company stock.
Largest 10 shareholders include FMR LLC (6.92M shares), Avoro Capital Advisors LLC (5.67M shares), Driehaus Capital Management LLC (4.6M shares), WELLINGTON MANAGEMENT GROUP LLP (3.84M shares), BRAIDWELL LP (2.71M shares), COMMODORE CAPITAL LP (2.7M shares), Capital World Investors (2.68M shares), Capital International Investors (2.58M shares), JANUS HENDERSON GROUP PLC (2.55M shares), and Polar Capital Holdings Plc (2.44M shares).
This table shows the top 203 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.